Department of Neurosurgery, University of California, San Diego-Rady Children's Hospital, San Diego, CA, USA.
Department of Neurosurgery, University of Utah, 175 North Medical Drive East, Salt Lake City, CA, USA.
Childs Nerv Syst. 2024 Aug;40(8):2419-2429. doi: 10.1007/s00381-024-06384-x. Epub 2024 Apr 18.
Pediatric intracranial aneurysms (IAs) are rare and have distinct clinical profiles compared to adult IAs. They differ in location, size, morphology, presentation, and treatment strategies. We present our experience with pediatric IAs over an 18-year period using surgical and endovascular treatments and review the literature to identify commonalities in epidemiology, treatment, and outcomes.
We identified all patients < 20 years old who underwent treatment for IAs at our institution between 2005 and 2020. Medical records and imaging were examined for demographic, clinical, and operative data. A systematic review was performed to identify studies reporting primary outcomes of surgical and endovascular treatment of pediatric IAs. Demographic information, aneurysm characteristics, treatment strategies, and outcomes were collected.
Thirty-three patients underwent treatment for 37 aneurysms over 18 years. The mean age was 11.4 years, ranging from one month to 19 years. There were 21 males (63.6%) and 12 females (36.4%), yielding a male: female ratio of 1.75:1. Twenty-six (70.3%) aneurysms arose from the anterior circulation and 11 (29.7%) arose from the posterior circulation. Aneurysmal rupture occurred in 19 (57.5%) patients, of which 8 (24.2%) were categorized as Hunt-Hess grades IV or V. Aneurysm recurrence or rerupture occurred in five (15.2%) patients, and 5 patients (15.2%) died due to sequelae of their aneurysms. Twenty-one patients (63.6%) had a good outcome (modified Rankin Scale score 0-2) on last follow up. The systematic literature review yielded 48 studies which included 1,482 total aneurysms (611 with endovascular treatment; 656 treated surgically; 215 treated conservatively). Mean aneurysm recurrence rates in the literature were 12.7% and 3.9% for endovascular and surgical treatment, respectively.
Our study provides data on the natural history and longitudinal outcomes for children treated for IAs at a single institution, in addition to our treatment strategies for various aneurysmal morphologies. Despite the high proportion of patients presenting with rupture, good functional outcomes can be achieved for most patients.
与成人颅内动脉瘤(IA)相比,儿科颅内动脉瘤(IA)较为罕见,且具有独特的临床特征。它们在位置、大小、形态、表现和治疗策略上存在差异。我们介绍了我们在过去 18 年中使用手术和血管内治疗治疗儿科 IA 的经验,并回顾了文献,以确定流行病学、治疗和结果方面的共同性。
我们确定了 2005 年至 2020 年期间在我们机构接受治疗的所有年龄小于 20 岁的 IA 患者。检查了病历和影像学检查以获取人口统计学、临床和手术数据。进行了系统评价,以确定报告儿科 IA 手术和血管内治疗主要结果的研究。收集了人口统计学信息、动脉瘤特征、治疗策略和结果。
33 名患者接受了 37 个动脉瘤的治疗,历时 18 年。平均年龄为 11.4 岁,范围从一个月到 19 岁。其中 21 名男性(63.6%)和 12 名女性(36.4%),男女比例为 1.75:1。26 个(70.3%)动脉瘤起源于前循环,11 个(29.7%)起源于后循环。19 例(57.5%)患者出现动脉瘤破裂,其中 8 例(24.2%)为 Hunt-Hess 分级 IV 或 V。5 例(15.2%)患者出现动脉瘤复发或再破裂,5 例(15.2%)患者因动脉瘤后遗症死亡。21 名患者(63.6%)在最后一次随访时的结果良好(改良 Rankin 量表评分 0-2)。系统文献复习共纳入 48 项研究,共计 1482 个动脉瘤(血管内治疗 611 个;手术治疗 656 个;保守治疗 215 个)。文献中血管内治疗和手术治疗的平均动脉瘤复发率分别为 12.7%和 3.9%。
除了我们对各种动脉瘤形态的治疗策略外,本研究还提供了单机构治疗的儿童 IA 的自然史和纵向结果数据。尽管大多数患者有破裂的高比例,但大多数患者都能获得良好的功能结果。